Transenterix Company Profile (NYSE:TRXC)

About Transenterix (NYSE:TRXC)

Transenterix logoTransEnterix, Inc. is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company's ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera. The system features advanced technology to enable surgeons with haptic feedback and the ability to move the camera through eye movement. The system replicates laparoscopic motion and integrates three-dimensional high definition (3DHD) vision technology. The ALF-X System also offers responsible economics to hospitals by offering robotic technology with reusable instruments. The SurgiBot System is designed as a single-incision, patient-side robotic-assisted surgery system. The Company also develops and manufactures laparoscopic surgical instruments that are used in abdominal surgery, such as scissors, graspers, clip appliers, and suction and irrigation instruments.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Equipment, Supplies & Distribution - NEC
  • Sub-Industry: N/A
  • Symbol: NYSE:TRXC
  • CUSIP: N/A
  • Web:
  • Market Cap: $108.43 million
  • Outstanding Shares: 148,536,000
Average Prices:
  • 50 Day Moving Avg: $0.70
  • 200 Day Moving Avg: $0.90
  • 52 Week Range: $0.45 - $2.33
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.97
  • P/E Growth: 0.0000
Sales & Book Value:
  • Annual Revenue: $5.05 million
  • Price / Sales: 21.47
  • Book Value: $0.83 per share
  • Price / Book: 0.88
  • EBIDTA: ($47,820,000.00)
  • Net Margins: -928.85%
  • Return on Equity: -49.16%
  • Return on Assets: -33.51%
  • Average Volume: 986,708 shs.
  • Short Ratio: 5.58

Frequently Asked Questions for Transenterix (NYSE:TRXC)

What is Transenterix's stock symbol?

Transenterix trades on the New York Stock Exchange (NYSE) under the ticker symbol "TRXC."

How were Transenterix's earnings last quarter?

Transenterix Inc (NYSE:TRXC) released its quarterly earnings results on Monday, March, 6th. The company reported ($0.12) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.11) by $0.01. Transenterix had a negative net margin of 928.85% and a negative return on equity of 49.16%. View Transenterix's Earnings History.

Where is Transenterix's stock going? Where will Transenterix's stock price be in 2017?

1 equities research analysts have issued 12-month price objectives for Transenterix's shares. Their predictions range from $2.75 to $2.75. On average, they anticipate Transenterix's share price to reach $2.75 in the next twelve months. View Analyst Ratings for Transenterix.

Are investors shorting Transenterix?

Transenterix saw a increase in short interest in the month of July. As of July 31st, there was short interest totalling 7,584,313 shares, an increase of 4.1% from the July 14th total of 7,286,423 shares. Based on an average trading volume of 753,393 shares, the days-to-cover ratio is currently 10.1 days. Approximately 7.8% of the shares of the stock are short sold.

Who are some of Transenterix's key competitors?

Who are Transenterix's key executives?

Transenterix's management team includes the folowing people:

  • Paul A. LaViolette, Independent Chairman of the Board
  • Todd M. Pope, President, Chief Executive Officer, Director
  • Joseph P. Slattery CPA, Chief Financial Officer, Executive Vice President, IR Contact Officer
  • Anthony Fernando, Chief Operating Officer
  • Andrea Biffi, Director
  • Dennis J. Dougherty, Independent Director
  • Jane H. Hsiao Ph.D., Independent Director
  • William N. Kelley M.D., Independent Director
  • Aftab R. Kherani M.D., Independent Director

How do I buy Transenterix stock?

Shares of Transenterix can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Transenterix's stock price today?

One share of Transenterix stock can currently be purchased for approximately $0.73.

MarketBeat Community Rating for Transenterix (NYSE TRXC)
Community Ranking:  2.6 out of 5 ( )
Outperform Votes:  91 (Vote Outperform)
Underperform Votes:  83 (Vote Underperform)
Total Votes:  174
MarketBeat's community ratings are surveys of what our community members think about Transenterix and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Transenterix (NYSE:TRXC) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $2.75 (276.71% upside)

Analysts' Ratings History for Transenterix (NYSE:TRXC)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
3/12/2017B. RileyReiterated RatingBuy$2.75MediumView Rating Details
1/19/2017Raymond James Financial, Inc.DowngradeOutperform -> Mkt PerformN/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
5/11/2016Lake Street CapitalDowngradeBuy -> Hold$2.00N/AView Rating Details
4/18/2016BTIG ResearchDowngradeBuy -> Neutral$6.00N/AView Rating Details
9/28/2015Royal Bank Of CanadaReiterated RatingOutperform$6.00N/AView Rating Details
(Data available from 8/18/2015 forward)


Earnings History for Transenterix (NYSE:TRXC)
Earnings by Quarter for Transenterix (NYSE:TRXC)
Earnings History by Quarter for Transenterix (NYSE TRXC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/6/2017Q4 2016($0.11)($0.12)ViewListenView Earnings Details
11/9/2016Q316($0.10)($0.11)$1.80 million$1.50 millionViewListenView Earnings Details
5/10/2016Q116($0.13)($0.12)ViewListenView Earnings Details
3/3/2016Q415($0.12)($0.13)ViewN/AView Earnings Details
8/6/2015Q215($0.15)($0.14)ViewN/AView Earnings Details
5/6/2015Q115($0.17)($0.16)$0.03 millionViewN/AView Earnings Details
2/24/2015Q414($0.18)($0.13)$50.00 million$0.13 millionViewN/AView Earnings Details
11/6/2014Q3($0.18)($0.18)$0.10 million$0.06 millionViewN/AView Earnings Details
5/7/2014($0.14)($0.15)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Transenterix (NYSE:TRXC)
Current Year EPS Consensus Estimate: $-0.40 EPS
Next Year EPS Consensus Estimate: $-0.37 EPS


Dividend History for Transenterix (NYSE:TRXC)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Transenterix (NYSE:TRXC)
Insider Trades by Quarter for Transenterix (NYSE:TRXC)
Institutional Ownership by Quarter for Transenterix (NYSE:TRXC)
Insider Trades by Quarter for Transenterix (NYSE:TRXC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/4/2017S.P.A SofarMajor ShareholderBuy3,722,685$1.40$5,211,759.00View SEC Filing  
8/22/2016Andrea BiffiDirectorBuy40,000$1.40$56,000.00View SEC Filing  
6/14/2016Anthony C J FernandoCTOBuy27,000$1.46$39,420.00View SEC Filing  
5/13/2016Joseph P SlatteryCFOBuy50,000$1.92$96,000.00View SEC Filing  
11/16/2015Andrea BiffiDirectorBuy25,000$2.81$70,250.00View SEC Filing  
11/13/2015Willam N KelleyDirectorBuy20,000$2.80$56,000.00View SEC Filing  
11/12/2015Joseph P SlatteryCFOBuy15,000$2.77$41,550.00View SEC Filing  
10/2/2014Joseph P SlatteryCFOSell33,000$4.19$138,270.00View SEC Filing  
9/8/2014Richard MuellerCOOSell3,000$3.60$10,800.00View SEC Filing  
9/8/2014Todd PopeCEOSell50,000$3.70$185,000.00View SEC Filing  
4/21/2014Aisling Capital Iii LpMajor ShareholderBuy1,037,767$4.00$4,151,068.00View SEC Filing  
4/21/2014William N Starling JrDirectorBuy221,450$4.00$885,800.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Transenterix (NYSE:TRXC)
Latest Headlines for Transenterix (NYSE:TRXC)
DateHeadline logoTransenterix Inc (NYSE:TRXC) Short Interest Up 4.1% in July - August 9 at 7:24 PM logoTransEnterix Announces First Senhance U.S. Innovation Center at Florida Hospital Orlando - August 4 at 9:17 AM logoInvestor Network: TransEnterix, Inc. to Host Earnings Call - August 3 at 8:07 AM logoTransEnterix, Inc. Reports Operating Results for the Second Quarter 2017 - August 3 at 8:07 AM logoTransEnterix reports 2Q loss - August 3 at 8:07 AM logoEdited Transcript of TRXC earnings conference call or presentation 2-Aug-17 8:30pm GMT - August 3 at 8:07 AM logoTransEnterix Announces Enhanced Capability to Perform Micro Incision Robotic Surgery - August 1 at 7:08 AM logoTransenterix Inc (NYSE:TRXC) Sees Large Growth in Short Interest - July 25 at 6:45 PM logoCan Intuitive Surgical’s Revenue Grow in 2017? - July 14 at 9:20 PM logoTransEnterix Schedules Second Quarter 2017 Financial and Operating Results Conference Call for August 2, 2017 - July 13 at 10:43 AM logoTransenterix Inc (NYSE:TRXC) Sees Large Decline in Short Interest - July 13 at 8:11 AM logo$870,000.00 in Sales Expected for Transenterix Inc (NYSE:TRXC) This Quarter - July 12 at 12:15 PM logo-$0.11 EPS Expected for Transenterix Inc (NYSE:TRXC) This Quarter - July 10 at 8:07 AM logoShort Interest in Transenterix Inc (TRXC) Declines By 1.1% - June 27 at 7:13 AM logoHead-To-Head Review: Luminex Corporation (LMNX) and Transenterix (TRXC) - June 17 at 10:26 PM logoEyeing FDA approval, TransEnterix makes first Senhance sale in Japan - June 17 at 6:50 AM logoTransenterix Inc (TRXC) Expected to Announce Quarterly Sales of $110,000.00 - June 16 at 7:16 PM logoTransEnterix (TRXC) Sells Senhance Robotic Surgery System at Saitama Medical University International Medical ... - - June 15 at 3:34 PM logoHalyard Health (HYH) vs. Transenterix (TRXC) Head-To-Head Analysis - June 12 at 12:16 PM logoTransenterix Inc (TRXC) Sees Large Increase in Short Interest - June 9 at 5:18 PM logoResearch Reports Initiation on Medical Supplies Stocks -- TransEnterix, Skyline Medical, Tandem Diabetes Care, and Merit Medical Systems - May 18 at 12:23 PM logoZacks: Analysts Expect Transenterix Inc (TRXC) to Announce -$0.11 Earnings Per Share - May 17 at 8:40 AM logoTransEnterix, Inc. Announces Loan Agreement with Innovatus Capital Partners, LLC - May 10 at 8:17 PM logoTransEnterix, Inc. Reports Operating Results for the First Quarter 2017 - May 10 at 8:17 PM logoTransEnterix reports 1Q loss - May 10 at 8:17 PM logoTransenterix Inc (TRXC) Short Interest Up 3.4% in April - May 9 at 6:56 PM logoTransEnterix (TRXC) Prices $24.9M Common Offering at $1 per 0.75 ... - - April 28 at 11:16 PM logoMid-Day Market Update: athenahealth Drops On Weak Results; Olympic Steel Shares Climb - April 28 at 11:16 PM logoTransEnterix (TRXC) Prices $24.9M Common Offering at $1 per 0.75 Share - April 28 at 11:16 PM logoTransEnterix stock gets hammered after hours on news of public offering - April 28 at 11:16 PM logoTransEnterix Announces Pricing of $24.9 Million Public Offering of Common Stock and Warrants - April 28 at 11:16 PM logo Brokerages Anticipate Transenterix Inc (TRXC) Will Post Quarterly Sales of $1.72 Million - April 28 at 3:34 PM logoTransEnterix Announces Proposed Public Offering of Common Stock and Warrants - April 27 at 9:58 PM logo Brokerages Expect Transenterix Inc (TRXC) Will Announce Earnings of -$0.12 Per Share - April 26 at 5:16 PM logoTransenterix Inc (TRXC) Short Interest Update - April 25 at 8:48 PM logoTransEnterix Schedules First Quarter 2017 Financial and Operating Results Conference Call for May 10, 2017 - April 25 at 7:16 PM logoTransenterix Inc (TRXC) Receives Consensus Rating of "Hold" from Brokerages - April 17 at 12:46 PM logoTransenterix Inc (TRXC) Sees Large Decline in Short Interest - April 12 at 7:05 AM logoZacks: Transenterix Inc (TRXC) Given $3.50 Consensus Target Price by Brokerages - April 6 at 9:52 AM



Transenterix (TRXC) Chart for Friday, August, 18, 2017

This page was last updated on 8/18/2017 by Staff